RecruitingPhase 1NCT07364357

A Phase I Study of CREPT-618 in Locally Advanced HCC

Studying Pediatric hepatocellular carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator
Ning Li, M.D.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Intervention
gene therapy(genetic)
Enrollment
13 enrolled
Eligibility
18-75 years · All sexes
Timeline
2025 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07364357 on ClinicalTrials.gov

Other trials for Pediatric hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Pediatric hepatocellular carcinoma →

← Back to all trials